Searching for early signs of lung injury after transfusion in ICU patients
Treatments studied
Part of Blood & lymphatic, Immune system & allergy, Lungs & breathing clinical trials.
This study looks for early markers in the blood that can predict a serious lung reaction called TRALI after a blood transfusion in ICU patients. It compares blood samples from different groups to find these markers, which could help prevent future reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in the intensive care unit (ICU).
- You could have no lung injury and have received a transfusion of red blood cells or platelets.
- You could have indirect ARDS (a lung condition caused by another illness) with or without a transfusion.
- You could have pneumonia with or without a transfusion.
- You must not have lung injury caused by multiple blood transfusions.
- You must not have a massive hemorrhage or object to data use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test measuring fibrinogen and albumin levels can help predict if someone with a traumatic brain injury will develop a serious lung condition called acute respiratory distress syndrome (ARDS). It may help doctors identify patients who need extra monitoring and care.
This study looks at a blood marker (EV-TF) to see whether it helps predict pulmonary embolism—blood clots in the lungs—in people with ARDS who are in the ICU. Results may help doctors better identify who is at higher risk.
This study looks at different patterns in patients with a severe lung condition called ARDS, to better understand why some respond to treatments differently. You may help doctors learn how to personalize care.
This study looks for markers in the blood and signs of air trapped in the lung tissue of people with acute respiratory distress syndrome (ARDS). It uses CT scans to understand why air leaks happen and if certain lab tests can predict them.
This study is testing whether certain proteins in the blood (sRAGE, CC16, and Syndecan-1) can help predict if patients with severe chest trauma will develop a serious lung condition called ARDS or have a higher risk of death. By measuring these proteins early, doctors might be able to identify high-risk patients sooner and provide more targeted care.
This study looks at how many people with serious injuries could receive a blood transfusion before reaching the hospital. It helps doctors understand if giving blood during emergency transport is a realistic option for major trauma patients.
Hear when a new ARDS, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.